Overview

Efficacy and Safety Study of Ticagrelor

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
General Hospital of Chinese Armed Police Forces
Treatments:
Clopidogrel
Ticagrelor
Ticlopidine
Criteria
Inclusion Criteria:

- 1.Clinical diagnosis of ACS 2.undergoing PCI 3.with clopidogrel resistance

Exclusion Criteria:

- 1.any contraindication against the use of clopidogrel and ticagrel 2.Contradiction to
aspirin and contrast medium 3.Life expectancy less than 1 year 4.Tumor or inflammatory
diseases5. fibrinolytic therapy within 24 hours before randomization 6.a need for oral
anticoagulation therapy 7. an increased risk of bradycardia 8.concomitant therapy with
a strong cytochrome P-450 3A inhibitor or inducer 9.a history of asthma.